Skip to main content

Table 1 Types of chemotherapies received by patients treated with chemotherapy

From: Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2–negative advanced breast cancer from the United States, Europe, and Israel

Current Therapy, n (%)

Chemotherapy Patients (n = 58)

Carboplatin

23 (39.7)

Paclitaxel

17 (29.3)

Cyclophosphamide

11 (19.0)

Capecitabine

8 (13.8)

Nab-Paclitaxel

7 (12.1)

Cisplatin

6 (10.3)

Vinorelbine

6 (10.3)

Gemcitabine

6 (10.3)

Doxorubicin Liposomal

5 (8.6)

Doxorubicin

4 (6.9)

Epirubicin

4 (6.9)

Eribulin

3 (5.2)

Docetaxel

1 (1.7)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us